WallStSmart

Crane NXT Co (CXT)vsEnnis Inc (EBF)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Crane NXT Co generates 358% more annual revenue ($1.80B vs $393.82M). EBF leads profitability with a 10.8% profit margin vs 7.8%. EBF trades at a lower P/E of 12.9x. CXT earns a higher WallStSmart Score of 63/100 (C+).

CXT

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 5.3Quality: 4.0
Piotroski: 2/9Altman Z: 1.47

EBF

Buy

60

out of 100

Grade: C+

Growth: 3.3Profit: 6.5Value: 6.0Quality: 9.0
Piotroski: 4/9Altman Z: 6.11
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CXT.

EBFSignificantly Overvalued (-60.2%)

Margin of Safety

-60.2%

Fair Value

$12.81

Current Price

$21.30

$8.49 premium

UndervaluedFair: $12.81Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CXT3 strengths · Avg: 8.0/10
Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
22.0%8/10

Revenue surging 22.0% year-over-year

EPS GrowthGrowth
41.9%8/10

Earnings expanding 41.9% YoY

EBF5 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
6.1110/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.738/10

Growing faster than its price suggests

P/E RatioValuation
12.9x8/10

Attractively priced relative to earnings

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

CXT4 concerns · Avg: 2.8/10
Profit MarginProfitability
7.8%3/10

7.8% margin — thin

Debt/EquityHealth
1.163/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.472/10

Distress zone — elevated risk

EBF3 concerns · Avg: 3.7/10
Revenue GrowthGrowth
1.5%4/10

1.5% revenue growth

EPS GrowthGrowth
3.2%4/10

3.2% earnings growth

Market CapQuality
$539.87M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : CXT

The strongest argument for CXT centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 22.0% demonstrates continued momentum.

Bull Case : EBF

The strongest argument for EBF centers on Debt/Equity, Altman Z-Score, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bear Case : CXT

The primary concerns for CXT are Profit Margin, Debt/Equity, Piotroski F-Score.

Bear Case : EBF

The primary concerns for EBF are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

CXT profiles as a growth stock while EBF is a value play — different risk/reward profiles.

CXT carries more volatility with a beta of 1.07 — expect wider price swings.

CXT is growing revenue faster at 22.0% — sustainability is the question.

CXT generates stronger free cash flow (49M), providing more financial flexibility.

Bottom Line

CXT scores higher overall (63/100 vs 60/100) and 22.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crane NXT Co

INDUSTRIALS · BUSINESS EQUIPMENT & SUPPLIES · USA

Crane NXT, Co. focuses on payment and merchandising technologies. The company is headquartered in Stamford, Connecticut.

Ennis Inc

INDUSTRIALS · BUSINESS EQUIPMENT & SUPPLIES · USA

Ennis, Inc. designs, manufactures, and sells business forms and other business products in the United States. The company is headquartered in Midlothian, Texas.

Want to dig deeper into these stocks?